E-mail

E-mail a Wiley Online Library Link

Kathleen E Rogers, Henrik Keränen, Jacob D. Durrant, Joseline Ratnam, Allison Doak, Michelle R. Arkin and J. Andrew McCammon Novel Cruzain Inhibitors for the Treatment of Chagas’ Disease Chemical Biology & Drug Design 80

Article first published online: 27 JUN 2012 | DOI: 10.1111/j.1747-0285.2012.01416.x

Thumbnail image of graphical abstract

Trypanosoma cruzi, the etiological agent of Chagas’ disease, affects millions of individuals and current therapies are inadequate. Using an exhaustive virtual-screening and experimental-validation approach, we identify several small-molecule inhibitors of cruzain, an essential cysteine protease of the protozoan parasite T. cruzi. Optimization of these chemical scaffolds could lead to the development of direly needed novel drugs useful in the treatment of Chagas’ disease.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

Choose captcha format: Image or Audio. Click here if you need help.

SEARCH